?

Peraza Lisa

VP, Chief Accounting Officer
Heron Therapeutics, Inc.
US, San Diego [HQ]
CIK 1828266

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
24,237
Price per Share :
$1.52
Equivalence :
$36,840.24

Transaction History

  • M
    Form 4
    24,237 Shares After Transaction
    Value : $n/a
    $0.0
    07/13/23
  • Footnotes:
    #1 Restricted stock units convert into common stock on a one-for-one basis.
    #2 Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
  • M
    Form 4
    26,170 Shares After Transaction
    Value : $n/a
    $0.0
    07/13/23
  • F
    Form 4
    25,310 Shares After Transaction
    Value : $33,156.10
    $1,126.60
    07/13/23
  • M
    Form 4
    22,613 Shares After Transaction
    Value : $n/a
    $0.0
    04/13/23
  • M
    Form 4
    24,545 Shares After Transaction
    Value : $n/a
    $0.0
    04/13/23

Get PRO Today.

PRO unlocks 9 more insider transactions made by Peraza Lisa

Start Free PRO trial Subscribe to PRO